We would like to inform you that due to unforeseen circumstances beyond the organizer control, the "11th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems" (Pharma-2024), originally scheduled for March 18-20 in Singapore, has been rescheduled to take place from September 19-21, 2024, in Rome, Italy.
If you have already confirmed your participation at the event, please note that your registration and accommodation (if previously booked with us) will automatically be transferred to the new dates.
For any further information or inquiries, please do not hesitate to contact us at firstname.lastname@example.org or call us at +1 (702) 988 2320.
Title: Macrophage-stabilized drug crystals
Title: Engineered spatiotemporal delivery of morphogens for skeletal regeneration
Title: Transfection by cell-penetrating peptides
Title: Bioinspired Sequence-defined drug, protein and gene carriers by chemical evolution.
Title: Challenge and progress in delivering molecules to the brain.
Title: Targeted self-navigating multifunctional drug delivery vehicles driven by promiscuous landscape phage proteins.
Title: Nucleic acid based amphiphiles as soft materials for nanomedicine.
Title: Patient centric dug delivery systems: ODT (Oral Disintegrating Tablet) and ODF (Oral Disintegrating Film).
Title: Formulation of liposomal doxorubicin modified with Bombesin peptide for selective targeting of GRP receptors over-expressed by cancer cells.
Title: Development of receptor targeted nanocomplexes for delivery of RNA therapeutics to the lung.
Title: Drug delivery across the skin barrier using biocompatible thermoresponsive nanogels.
Title: Engineering endosomal escape using pHlexi particles.
Title: Aptamers as therapeutic agents in human cancers and evidence for glioblastoma targeting through the blood-brain-barrier of aptamer-functionalized nanosystems.
Title: Building a better antibody-based medicine: Antibody mimetic.
Title: Oral delivery of lipophilic drugs: The solubility-permeability interplay and formulation design.
Title: Inhalable therapy of pulmonary Tuberculosis mediated by polysaccharide microparticles.
Title: Driving endocytosis for enhancing cellular delivery and intracellular targeting of therapeutics.
Title: Dry powder inhalers - challenges and opportunities in delivering drugs to the lungs.
Title: Crystal Engineering of alternative solid forms of therapeutic agent.
Title: Anionophores, an emerging group of molecules to fight cancer.
Title: Lipoprotein based drug delivery platform.
Title: Impact of surface anisotropic forces on powder flowability.
Title: Novel ring-fused tetrapyrrolic macrocycles as very active photodynamic agents for cancer.
Title: Ex-vivo intraocular model to investigate long-term protein stability in vitreous humor.
Title: Development of microparticles loaded with pine bark extracts and evaluation of its bioavailability on fish.
Title: Can antibiotics treat cancer?
Title: Peptide-based therapeutics for the treatment of neurodegenerative diseases; challenges and opportunities.
Title: Polymer-based combination therapeutics.
Title: Hydrogen sulfide: A novel mediator and therapeutic target for inflammatory disease.
Title: Locust Bean Gum-based nanoparticles for oral immunization.
Title: Nanocomposite microparticles for the pulmonary delivery of bio-macromolecules.
Title: Development of nitroreductase/prodrug system for cancer therapy.
Title: Why perform pharmaceutical analysis green and optimized?
Title: INN Darunavir. Patenting problem of active pharmaceutical substances.
Title: Preclinical development of GMC1, a novel molecule targeting FKBP52 for the treatment of castration resistance prostate cancer.
Title: Development of formulations for novel chemotherapeutic agents for Tuberculosis and HIV coinfection.
Title: The bone-cartilage interface: A complex biological barrier with potential therapeutical target.
Title: Improvements of computational optimization of drug-target interactions.
Title: Towards improved activity and stability of gene therapeutics.
Title: Smart lipid nanocarriers: Potential for intracellular targeting.
Title: Potentiation of cytotoxic action of the new cisplatin derivative by UV irradiation.
Title: Impact of gut microbiota-mediated bile acid metabolism on the solubilization capacity of bile salt micelles and drug biopharmaceutical properties.
Title: Development of intravenous form of rifapentine and its in vivo evaluation.
Title: Green technology approach for development of BCS Class II molecule nanoformulation.
Title: Visualization and characterization of nanocarriers for dermal drug delivery using single molecule methods.